Showing 1071-1080 of 2822 results for "".
Progressive Drug-Resistant Epilepsy & Behavior Changes
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/progressive-drug-resistant-epilepsy-behavior-changes/31840/Early diagnosis of progressive epilepsy is essential.Sphenoid Wing Meningioma Presenting With a Temporal Fossa Mass
https://practicalneurology.com/diseases-diagnoses/imaging-testing/sphenoid-wing-meningioma-presenting-with-a-temporal-fossa-mass/32045/Dural-based meningioma with intraosseous involvement and extension into the temporal and infratemporal fossa is a rare occurrence, seen in only 2% of people with meningiomas.Neuro-ophthalmology Options: Secondary Causes of Eye Pain
https://practicalneurology.com/diseases-diagnoses/headache-pain/neuro-ophthalmology-options-secondary-causes-of-eye-pain/31794/A localization approach and good clinical history and examination can help diagnose the 45% of eye pain not caused by migraine or trigeminal neuralgias.Headache Horizons: Migraine Triggers
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-horizons-migraine-triggers/31946/What should clinicians know and share with patients about migraine triggers?Ethical Neurologic Care During a Pandemic
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/ethical-neurologic-care-during-a-pandemic/31741/Our ethical duty is to provide equitable care, minimize harm, respect autonomy, and maintain trust.Building an Infrastructure to Administer Amyloid-Targeting Treatments
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/building-an-infrastructure-to-administer-amyloid-targeting-treatments/36187/With the introduction of amyloid-targeting therapies, clinicians face a welcome but challenging paradigm shift, requiring new clinical systems and workflows, interdisciplinary teams, and technical expertise.Parkinson Disease Treatment Advances
https://practicalneurology.com/diseases-diagnoses/movement-disorders/parkinson-disease-treatment-advances/31935/New agents, formulations, and procedures to improve Parkinson disease treatment.Neuromodulation Strategies for Lennox-Gastaut Syndrome: A New Frontier
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/neuromodulation-strategies-for-lennox-gastaut-syndrome-a-new-frontier/39964/The evolution of neuromodulation strategies for the management of Lennox- Gastaut syndrome emphasizes the role of targeted thalamic stimulation, the importance of individualized approaches, and the need for further research to optimize treatment efficacy.Headache Medicine Update: What’s New in CGRP Functional Blocking Agents
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-medicine-update-whats-new-in-cgrp-functional-blocking-agents/32126/CGRP blocking agents have demonstrated success in migraine treatment and can be used in various settings, in different combinations, and for different headache conditions.Updates in Bruton Tyrosine Kinase Inhibition for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/updates-in-bruton-tyrosine-kinase-inhibition-for-multiple-sclerosis/31975/Ongoing clinical trials will elucidate potential advantages and safety of these novel medications for future treatment of multiple sclerosis.